Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 91 points (0.6%) at 15,720 as of Friday, Feb. 7, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 2,156 issues advancing vs. 753 declining with 162 unchanged. The Health Services industry currently sits up 0.6% versus the S&P 500, which is up 0.6%. A company within the industry that fell today was Aetna ( AET), up 2.4%. Top gainers within the industry include St Jude Medical ( STJ), up 2.8%, Smith & Nephew ( SNN), up 2.2%, Boston Scientific ( BSX), up 2.1%, Thermo Fisher Scientific ( TMO), up 2.1% and Becton Dickinson ( BDX), up 1.6%. TheStreet would like to highlight 4 stocks pushing the industry lower today: 4. Laboratory Corporation of America Holdings ( LH) is one of the companies pushing the Health Services industry lower today. As of noon trading, Laboratory Corporation of America Holdings is down $2.10 (-2.3%) to $88.22 on average volume. Thus far, 791,025 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $87.52-$91.39 after having opened the day at $88.86 as compared to the previous trading day's close of $90.32. Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $7.8 billion and is part of the health care sector. Shares are down 1.1% year-to-date as of the close of trading on Thursday. Currently there are 4 analysts that rate Laboratory Corporation of America Holdings a buy, 1 analyst rates it a sell, and 12 rate it a hold. TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Laboratory Corporation of America Holdings Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.